Cargando…
When rheumatology meets hepatology: are anti-TNFs safe in hepatitis B virus carriers?
Over the past decades, more effective and less toxic biologicals have revolutionized rheumatology therapy in our battle against the autoimmune chronic inflammation of rheumatoid arthritis and spondyloarthropathy. But what about for patients who have previously had an infection of the liver? Prior he...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875626/ https://www.ncbi.nlm.nih.gov/pubmed/20156318 http://dx.doi.org/10.1186/ar2899 |